Edition:
United Kingdom

Brainstorm Cell Therapuetics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

4.20USD
3:55pm BST
Change (% chg)

$0.02 (+0.48%)
Prev Close
$4.18
Open
$4.17
Day's High
$4.20
Day's Low
$4.17
Volume
372
Avg. Vol
24,476
52-wk High
$5.34
52-wk Low
$2.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.121
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
FY 2016 Dec '16 0.00 -0.033
Sep '16 0.00 -0.086
Jun '16 0.00 -0.052
Mar '16 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 1.50 1.50 1.50 --
Quarter Ending Dec-18 1 1.50 1.50 1.50 --
Year Ending Dec-18 2 2.25 4.50 0.00 0.00
Year Ending Dec-19 2 3.00 6.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 2 -0.14 -0.12 -0.17 -0.24
Quarter Ending Dec-18 2 -0.20 -0.15 -0.26 -0.28
Year Ending Dec-18 2 -0.57 -0.51 -0.64 -1.05
Year Ending Dec-19 2 -0.64 -0.44 -0.85 -1.08
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.33 32.76
P/E High - Last 5 Yrs. -- 298.33 45.44
P/E Low - Last 5 Yrs. -- 91.43 24.26
Beta 1.54 0.93 0.89
Price to Sales (TTM) -- 112.52 5.73
Price to Book (MRQ) 10.34 15.54 5.47
Price to Tangible Book (MRQ) 10.39 14.64 7.05
Price to Cash Flow (TTM) -- 72.59 23.29
% Owned Institutions 12.71 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.35 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 408.02 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 79.88 5.64
Sales - 5 Yr. Growth Rate -- 32.06 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.62 29.02 20.60
EPS (TTM) vs TTM 1 Yr. Ago 25.48 -- --
EPS - 5 Yr. Growth Rate -- 39.49 10.66
Capital Spending - 5 Yr. Growth Rate 16.50 39.97 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 10.80 5.50 3.03
LT Debt to Equity (MRQ) 0.00 34.92 12.51
Total Debt to Equity (MRQ) 0.00 36.72 16.84
Interest Coverage (TTM) -- -101.16 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.68 54.37
Gross Margin - 5 Yr. Avg. -- 50.98 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -586.56 10.81
Operating Margin (TTM) -- -733.21 4.58
Operating Margin - 5 Yr. Avg. -- -608.15 6.24
Pre-Tax Margin (TTM) -- -707.36 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -611.67 6.68
Net Profit Margin (TTM) -- -708.75 1.73
Net Profit Margin - 5 Yr. Avg. -- -614.69 2.95
Effective Tax Rate (TTM) -- 23.23 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,025,841 860,395,327
Net Income/Employee (TTM) -- 3,117,868 101,209,600
Receivable Turnover (TTM) -- 20.74 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.79 0.27 11.14
Return on Assets - 5 Yr. Avg. -71.19 3.72 12.40
Return on Investment (TTM) -52.76 2.22 14.61
Return on Investment - 5 Yr. Avg. -91.15 2.89 16.14
Return on Equity (TTM) -52.76 3.86 16.34
Return on Equity - 5 Yr. Avg. -93.46 3.83 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapuetics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.84%
# of Holders: 41
Total Shares Held: 1,688,567
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.